HemoSonics, LLC is a medical device company founded to develop and bring to market innovative diagnostics to quantify and characterize the hemostatic potential of whole blood. Our mission is to save lives and improve the quality of life while reducing costs through the use of our products in all applicable clinical settings.

The formation of a blood clot and its successive dissolution, known as the hemostatic balance, is required to arrest blood loss from an injured vessel. However, disruption of this balance leads to hemostatic disorders with either excessive bleeding or excessive clotting (thrombosis). These disorders, manifested as heart attack, stroke, pulmonary embolism, excessive bleeding and other conditions, are responsible for over 30% of all deaths in the developed world. HemoSonics’ products, based on a patented technology, will enable fast and accurate assessment of hemostasis and guide appropriate medical treatment in a variety of clinical settings.